SMT201300059B - Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione - Google Patents

Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione

Info

Publication number
SMT201300059B
SMT201300059B SM201300059T SM201300059T SMT201300059B SM T201300059 B SMT201300059 B SM T201300059B SM 201300059 T SM201300059 T SM 201300059T SM 201300059 T SM201300059 T SM 201300059T SM T201300059 B SMT201300059 B SM T201300059B
Authority
SM
San Marino
Prior art keywords
biopolymer
incorporating
production
acid produced
fusidic acid
Prior art date
Application number
SM201300059T
Other languages
English (en)
Italian (it)
Inventor
Vanangamudi Subramaniam Sulur
Madhavan Srinivasan
Neelakandan Narayanan Chulliel
Kuppusamy Senthilkumar
Original Assignee
Vanangamudi Subramaniam Sulur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanangamudi Subramaniam Sulur filed Critical Vanangamudi Subramaniam Sulur
Publication of SMT201300059B publication Critical patent/SMT201300059B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201300059T 2009-04-13 2013-06-05 Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione SMT201300059B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN960MU2009 2009-04-13
PCT/IB2010/051552 WO2010119385A1 (fr) 2009-04-13 2010-04-12 Crème médicinale à base d'acide fusidique produite au moyen de fusidate de sodium et incorporant un biopolymère et son procédé de fabrication

Publications (1)

Publication Number Publication Date
SMT201300059B true SMT201300059B (it) 2013-07-09

Family

ID=42558569

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201300059T SMT201300059B (it) 2009-04-13 2013-06-05 Crema medicinale a base di acido fusidico prodottausando fusidato di sodio e incorporante un biopol inimero e procedimento per la sua produzione

Country Status (19)

Country Link
US (1) US8895542B2 (fr)
EP (1) EP2419087B1 (fr)
JP (1) JP5205549B2 (fr)
KR (1) KR101642537B1 (fr)
CN (1) CN102159191B (fr)
BR (1) BRPI1006729B1 (fr)
CA (1) CA2795611C (fr)
CY (1) CY1113885T1 (fr)
DK (1) DK2419087T3 (fr)
ES (1) ES2404156T3 (fr)
HR (1) HRP20130149T1 (fr)
IL (1) IL215641A (fr)
MX (1) MX2011010784A (fr)
PL (1) PL2419087T3 (fr)
PT (1) PT2419087E (fr)
RU (1) RU2537023C2 (fr)
SI (1) SI2419087T1 (fr)
SM (1) SMT201300059B (fr)
WO (1) WO2010119385A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101457789B1 (ko) 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
US9909123B2 (en) 2013-03-15 2018-03-06 Techulon Inc. Antisense molecules for treatment of Staphylococcus aureus infection
WO2017091167A1 (fr) 2015-11-28 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Composition pharmaceutique topique comprenant de l'acide fusidique, de l'isoconazole, du dexpanthénol et de l'hydrocortisone
KR20230031370A (ko) 2017-06-12 2023-03-07 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도
CN107224426A (zh) * 2017-07-08 2017-10-03 天津双硕医药科技有限公司 一种含有夫西地酸的外用乳膏组合物
CN111012747B (zh) * 2018-10-10 2022-11-25 四川海思科制药有限公司 一种注射用夫西地酸钠药物组合物及其制备方法
CN114432250B (zh) * 2022-02-22 2022-10-04 深圳市泰力生物医药有限公司 一种非晶态夫西地酸的稳定方法
WO2025099639A1 (fr) 2023-11-08 2025-05-15 Sulur Vishagan Vanangamudi Compositions et méthodes de traitement d'affections cutanées

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500310D0 (en) * 1985-01-07 1985-02-13 Leo Pharm Prod Ltd Pharmaceutical preparation
SU1380751A2 (ru) * 1986-03-12 1988-03-15 Всесоюзный научно-исследовательский институт антибиотиков Средство дл лечени гнойно-воспалительных заболеваний кожи и м гких тканей
DK603988D0 (da) * 1988-10-28 1988-10-28 Klaus Bendtzen Farmaceutisk praeparat
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
PL190023B1 (pl) * 1997-11-25 2005-10-31 Yamanouchi Europ Bv Zastosowanie mieszaniny diolu i alfa-hydroksykwasu do wytwarzani leku do leczenia hiperkeratozowychchorób skóry
US20070265352A1 (en) * 2002-02-19 2007-11-15 Joachim Roeding Synergistic mixtures of at least one 1,2 alkanediol such as 1,2-hexanediol and 1,2-octanediol with a further compound having antimicrobial properties
ES2204331B1 (es) 2002-10-09 2005-03-01 Ercros Industrial, S.A. Procedimiento para la obtencion de acido fusidico a partir de un caldo de fermentacion.
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
RU2240781C1 (ru) * 2003-06-05 2004-11-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения воспалительных процессов вульвы и влагалища
EP1740590A1 (fr) * 2004-03-16 2007-01-10 Glaxo Group Limited COMPOSES DE PYRAZOLO [3,4-b] PYRIDINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE PDE4
BRPI0707367A2 (pt) * 2006-02-02 2011-05-03 Leo Pharma As composição farmacêutica, uso de uma composição, e, método de prevenir ou tratar uma doença dérmica ou condição da pele ou mucosa
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
US20080182819A1 (en) * 2007-01-29 2008-07-31 Act Iii Licensing, Llc Chitosan compositions and methods for using chitosan compositions in the treatment of health disorders
NZ594021A (en) 2008-12-19 2013-10-25 Sulur Subramaniam Vanangamudi A novel dermaceutical cream made using sodium fusidate
RU2536426C2 (ru) * 2009-02-18 2014-12-20 Сулур Субраманиам ВАНАНГАМУДИ Способ изготовления крема, содержащего фусидовую кислоту

Also Published As

Publication number Publication date
US8895542B2 (en) 2014-11-25
RU2011146230A (ru) 2013-05-20
CA2795611C (fr) 2016-09-20
PL2419087T3 (pl) 2013-06-28
HRP20130149T1 (hr) 2013-03-31
JP5205549B2 (ja) 2013-06-05
CY1113885T1 (el) 2016-07-27
US20120040946A1 (en) 2012-02-16
PT2419087E (pt) 2013-04-26
RU2537023C2 (ru) 2014-12-27
WO2010119385A1 (fr) 2010-10-21
JP2012523451A (ja) 2012-10-04
BRPI1006729B1 (pt) 2021-10-05
ES2404156T3 (es) 2013-05-24
KR101642537B1 (ko) 2016-07-25
CN102159191B (zh) 2014-04-02
CN102159191A (zh) 2011-08-17
DK2419087T3 (da) 2013-05-06
IL215641A0 (en) 2012-01-31
IL215641A (en) 2014-09-30
EP2419087B1 (fr) 2013-01-23
KR20120023653A (ko) 2012-03-13
CA2795611A1 (fr) 2010-10-21
BRPI1006729A2 (pt) 2020-10-06
SI2419087T1 (sl) 2013-06-28
MX2011010784A (es) 2012-01-12
EP2419087A1 (fr) 2012-02-22

Similar Documents

Publication Publication Date Title
DK3006024T3 (da) Benzoesyre eller salte deraf til forstærkning af aktiviteten af et neurofarmaceutisk lægemiddel
PL2242515T3 (pl) Sposób wytwarzania formulacji farmaceutycznej środków kontrastowych
EP2569483A4 (fr) Procédé de production d'une composition comprenant de la cellulose fibrillée et composition
HUE042945T2 (hu) Kvetiapin zsírsav-konjugátumai, eljárás ugyanannak elkészítésére és felhasználására
EP2548965A4 (fr) Procédé de production d'une solution de sucre et dispositif afférent
BRPI1014760A8 (pt) preparação compreendendo insulina, nicotinamida e um aminoácido
EP2545178A4 (fr) Production d'acide par fermentation
EP2548966A4 (fr) Procédé de production d'une solution de sucre et dispositif afférent
BR112013011997A2 (pt) "métodos para produzir uma solução aquosa concentrada de açúcar e para produzir etanol como uso de uma levedura"
FR2948364B1 (fr) Procede de preparation d'un fluorure d'halogenoacetyle et de ses derives
SMT201500204B (it) Procedimento per preparare un acido bivenil-2-il carbammico
BRPI1015297A2 (pt) "método para a preparação de produtos de clivagem de carboidratos a partir de um material lignocelulósico".
BR112012024034A2 (pt) produto de confeitaria e métodos de sua produção
SI2419087T1 (sl) Medicinska krema na osnovi fusidne kisline, izdelana z uporabo natrijevega fusidata in vsebujoča biopolimer in postopek za njeno izdelavo
ITUD20110133A1 (it) "sensore di integrazione ad azione ritardata cmos per applicazione in produzione di immagini a raggi x"
EP2448423A4 (fr) Production d'isolats de protéine de soja solubles dans un acide (« s700 »)
ZA201200821B (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
FR2954313B1 (fr) Procede de preparation de dithiocarbamates notamment a partir de polyols du type glycerol.
FI20080348A0 (fi) Uudenlainen farmaseuttinen formulaatio
EP2788516A4 (fr) Démarrage d'un processus de fusion
PL2403480T3 (pl) Sposób wytwarzania kremu z kwasem fusydowym
WO2010134048A3 (fr) Solutions de rétinoïdes topiques
EP2728904A4 (fr) Élément vibrant et procédé de production d'un élément vibrant
IT1399692B1 (it) Metodo e impianto per la preparazione di un prodotto granulato
EP2788514A4 (fr) Démarrage d'un processus de fusion